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Strengths and limitations of this study
 ► Multidisciplinary team of authors including stake-
holders, clinical and health psychologists, academ-
ics, healthcare providers (doctors and nurses) will 
lead this scoping review.
 ► Comprehensive three-tiered search strategy will be 
utilised to enhance inclusion of existing empirical 
and grey literature sources.
 ► This study follows a validated methodological 
framework along with peer-reviewed search strat-
egy and systematic data analysis.
 ► This scoping review is limited to English language 
only.
 ► Scoping reviews do not have quality of evidence 
evaluation compared with systematic review.
AbStrACt
Introduction Chronic obstructive pulmonary disease 
(COPD) is a common respiratory condition that causes 
persistent respiratory symptoms and decline in 
lung function over many years. This chronic disease 
significantly affects health-related quality of life and is 
known to contribute to frequent emergency department 
(ED) presentations. Multidimensional management of these 
patients, including interconnecting health disciplinarians 
will allow holistic care provision in the ED. The purpose 
of this scoping review is to synthesise current evidence 
on holistic management and assessment, and referral 
practices stemming from acute COPD presentation in the 
ED. Specifically, to determine: (1) What are the known 
causal factors associated with COPD ED presentations 
and (2) Is there an identified connection with appropriate 
healthcare professional assessment within ED 
presentations and reported referral pathways?
Methods and analysis The iterative stages of the 
Arskey and O’Malley, and Levac advanced scoping 
review framework informs this review. Using published 
and unpublished studies in English, a three-tiered 
search strategy will be applied. After duplicates are 
removed, screen 1 (title and abstract) and screen 2 (full-
text) will be conducted by two independent reviewers 
to determine eligibility of articles. Disputes will be 
settled through discussion or by using a third reviewer. 
A data collection tool developed by the authors will 
inform the data extraction process. Schematic tabular 
format of results with a narrative summary will depict 
how the results link with the scoping review objectives. 
Categorisation of results will be narrowed down as key 
conceptual findings and will align with the strategic 
intent of this review.
Ethics and dissemination Ethics approval was not 
required for this study. A multidisciplinary team of authors 
will participate in dissemination activities (publications, 
reports, conference presentations, framework 
development).
IntroduCtIon
Chronic obstructive pulmonary disease 
(COPD) is a common respiratory condition 
that causes persistent airflow limitation, 
inflammation and pathological damage to the 
lungs with varying involvement of the small 
airways and/or lung parenchyma leading 
to lung function decline over many years.1 
Symptoms of acute exacerbation of COPD 
(AECOPD) can include chronic dyspnoea, 
cough and exercise intolerance, which aggra-
vate and worsen these symptoms.2 Yang et al 
define AECOPD as a change in the patient’s 
normal dyspnoea, cough or sputum produc-
tion that has surpassed baseline variations in 
symptoms, is acute in onset and may warrant 
medication alteration or hospital admission.2 
Patients experiencing AECOPD frequently 
present to the emergency department (ED) 
for acute management of their symptoms.2 
COPD is a significant cause of morbidity 
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and mortality for patients in Australia and worldwide. 
Currently, it is the fourth leading cause of death in 
the world and the leading cause of health burden in 
Australia within the age group of 65–74 and 75–84 years.3 
In Australia, 1 in 7 people aged 40 years and over have 
some form of COPD and the rate of hospitalisation for 
COPD among those aged 55 years and over was 1052 per 
100 000 in 2015.4 The Australian Institute of Health and 
Welfare indicate that COPD is one of the top two causes 
of avoidable hospital presentations and is increasing.3 
Smoking or passive smoking has been recognised globally 
as the primary cause of COPD.5 Other leading risk factors 
include occupational exposure to dusts and fumes, 
indoor and outdoor air pollution, psychosocial stressors, 
associated comorbidities like cor pulmonale, and both 
viral and bacterial infections.2 6–8
The literature relating to ED management of 
AECOPD focuses on a number of key areas including 
the frequency of AECOPD presentations, prognosis 
following presentation and adherence to clinical guide-
lines. Patients with COPD can experience significant 
and escalating symptoms which often result in frequent 
and recurring ED visits and hospital admissions.7 9 This 
was demonstrated in a large cohort study by Hasegawa et 
al which found that 29% of AECOPD ED presentations 
were representations and noted a correlation between 
increased morbidity and the number of ED visits for 
AECOPD.10 Repeat visits to the ED are significant in the 
trajectory of the disease because patients with COPD 
who present to the ED notably require hospitalisation 
and have been recorded as having a poorer prognosis.7 8 
This reduced prognosis results from loss of lung func-
tion, and causes increased physical and psychological 
morbidity for patients.2 11
A holistic approach towards patients presenting to 
the ED with AECOPD must ensure consideration of 
physical, spiritual, emotional, mental and social factors 
that affect the patient’s overall well-being as defined by 
Wade.12 Holistic approaches can provide patients with 
optimal prognosis and outcomes.12 Improvement in 
holistic assessment and referral frameworks are required 
to improve health-related quality of life for people with 
COPD who present to the ED.13 Initiation of consistent 
interdisciplinary healthcare interventions for patients 
with COPD presenting to the ED may also reduce anxiety 
related readmissions and empower patients and their 
family.13 Further research is pivotal in this area to identify 
optimal holistic ED management and referral pathways 
for COPD presentations. This review considers a colla-
tion of known causal factors for AECOPD to ED as a key 
step to better understanding where core members of an 
interprofessional healthcare team are being underuti-
lised. The intention then is to better inform assessment 
and referral framework for ED AECOPD management. 
Improved healthcare intervention is known to break this 
perpetuating cycle of symptoms including its complex 
interaction with mental health disorders like depression 
and anxiety.11
At present, no scoping reviews have specifically exam-
ined holistic COPD ED assessment and referral patterns. 
However, a systematic review by Pederson et al recognised, 
evaluated and synthesised available evidence on the effec-
tiveness of targeted discharge interventions that can 
reduce readmission of patients with AECOPD, although 
this review was not interprofessional or holistic.14 In 
addition, a systematic review undertaken by Domingo et 
al examined and synthesised literature related to struc-
tured discharge processes in decreasing hospital readmis-
sion for patients with community acquired pneumonia.15 
However, neither of these reviews have considered recom-
mendations and practices for holistic COPD assessment 
and referral patterns in ED presentations. Rather their 
core focus was on discharge planning intervention alone 
in the reduction of readmission. The notable difference 
with this scoping review is to extend the existing research 
and understanding to better identify the true root 
causes of COPD ED presentations and ensure that these 
patients are connected with the most appropriate inter-
disciplinary referral (eg, anxiety as a presenting symptom 
being referred to a psychologist).
Unfortunately, current ED care models frequently view 
symptoms and disease unidimensional, thereby leaving 
potential gaps in the identification of causal factors for ED 
presentations.16 New approaches to categorise and docu-
ment different clinical characteristics of COPD presen-
tations are required and the inclusion of psychology, 
social work, pharmacy, physiotherapy, dietetics, nursing, 
smoking cessation, vaccination, self-management and 
general practitioner liaison prior to discharge may reduce 
relapse and hospital stays.9 13 14 This complete approach 
with specific interprofessional interventions would better 
target the unique needs of patients with COPD, with 
the long-term goal to reduce representation to the ED. 
In addition, holistic interprofessional intervention that 
address psychological and physical consequences of an 
AECOPD will ultimately improve patient self-manage-
ment and outcomes.9 14 Accurate integration of these 
services with interdisciplinary health professionals has 
the potential to improve disease-related quality of life, 
exercise capacity and reduced hospital days per diag-
nosed person.13
objective
The purpose of this scoping review is to examine the 
current holistic assessment and management of patients 
with AECOPD following presentation to an ED, by thor-
oughly investigating causal factors that contribute to 
AECOPD ED presentations and consequences of an exac-
erbation (eg, decline in physical function, anxiety and so 
on). Causal factors (also known as risk factors) for this 
scoping review will be defined as those outlined in the 
COPD-X Plan: Australian and New Zealand Guidelines 
for the management of COPD, such as (but not limited 
to) cigarette smoking, indoor and outdoor air pollution, 
respiratory infection and medication non-compliance.2 
This scoping review is part of a much larger multisite 
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research study funded by the Emergency Medicine Foun-
dation. The scoping review is linked to (1) a broader 
exploration of Queensland Health data systems summary 
of individual characteristics associated with avoidable 
COPD admissions, (2) a complete health economic 
analysis regarding costs associated with COPD service 
over-utilisation and (3) will inform a modified Delphi 
Study, which intends to develop a holistic ED COPD 
assessment framework integrating appropriate health 
professional referral pathways.
MEthodS And AnAlySIS
This scoping review will apply the iterative stages of the 
Arskey and O’Malley, and Levac advanced scoping review 
framework.17–19 This reflexive and iterative approach will 
facilitate continuous refinement as the scoping review 
progresses through the screening and data extraction 
stages. This will be supplemented with the Preferred 
Reporting Items for Systematic reviews and Meta-Analyses 
extension for Scoping Reviews (PRISMA-ScR) checklist 
guidelines.20 The Arskey and O’Malley established frame-
work and PRISMA-ScR guidelines provide rigorous and 
transparent processes in identifying eligible literature for 
a scoping review that effectively maps the available body of 
research.19 EndNote referencing libraries will be used to 
manage records during each stage of the scoping review. 
The initial planning for the scoping review commenced in 
July 2018. It is anticipated that the review will commence 
early in June 2019, with a desired completion date of June 
2020.
Stage 1: defining the research question
This scoping review will explore known causes of COPD 
presentations in the ED among both academic and grey 
literature. Identification of current interdisciplinary 
initiatives available to these patients around the world 
will inform holistic management recommendations for 
patients with COPD in the ED.
1. What are the known causal factors associated with 
COPD ED presentations?
2. Is there an identified connection with appropriate 
healthcare professional assessment within ED presen-
tations and reported referral pathways?
Stage 2: identifying relevant literature
A search of the JBI Database of Systematic Reviews and 
Implementation Reports, CINAHL, The Cochrane Data-
base of Systematic Reviews, Google Scholar, PubMed and 
ProQuest Dissertations and Theses was performed by the 
authors to ensure the originality of this scoping review on 
holistic COPD ED assessment and referral patterns. This 
scoping review will consider COPD studies within any ED 
context across all international geographical contexts. 
For the purposes of this scoping review, the types of 
studies will be ‘open’, allowing for the inclusion of (but 
not limited to) primary research studies, including quan-
titative, qualitative and mixed designs and systematic 
reviews. Other texts such as opinion pieces, discussion 
papers, position papers and practice guidelines will also 
be considered. Using published and unpublished studies, 
a three-tiered search strategy will apply for this review. An 
initial search of CINAHL and MEDLINE will commence, 
followed by examination of key search terms found in 
each title and abstract, and a match to the subject terms 
described in each article (see supplemental file appendix 
1, eg, electronic search strategy).
A second search using subject terms will then be 
adopted more extensively across The Cochrane Library, 
CINAHL, PubMed and JBI. Third, each reference list 
from studies selected for inclusion will be examined for 
any additional studies of relevance. Only studies written 
in the English language will be targeted as part of the 
search strategy due to time constraints. Studies published 
from 2008 onwards will be considered to ensure influ-
ential publications are identified with the most current 
evidence on known causal factors for COPD ED presen-
tations and reported referral pathways. Published and 
unpublished studies identified during the search phase 
will be screened to ensure the same article has only been 
included once and all duplicate articles will be elimi-
nated. Based on terms found in the title and abstract, two 
reviewers will assess identified studies for relevance to the 
review questions for moderation. The entire article will 
be extracted for studies considered appropriate for inclu-
sion and where a studies relevance is unclear from the 
abstract.18 Two reviewers will independently examine the 
fully extracted articles for their relevance in meeting the 
inclusion criteria. Disputes will be settled through discus-
sion or by using a third reviewer. All references from 
identified articles will be further examined for relevance 
through both the title and abstract.18
Stage 3: study selection
Eligibility criteria
This scoping review will only consider studies that focus 
on ED presentations for AECOPD by patients who 
are 18 years or over. For the purpose of this review, we 
define an ED as any medical facility or clinical practice 
setting designed for emergency care of patients in the 
event of an acute or urgent medical illness or injury and 
may be referred to as (but not limited to) accident and 
emergency department, emergency room or casualty 
department. COPD (also referred to as chronic obstruc-
tive airway disease, emphysema, chronic bronchitis or 
chronic bronchiolitis) must be the primary reason for ED 
presentation. Non-ED, paediatric and other non-COPD 
diagnostic related patient presentations (including other 
respiratory conditions such as asthma or cystic fibrosis) 
are not the focus of this review and will be excluded. 
This review will only consider research that investigates 
AECOPD (chronic bronchitis or emphysema) to the ED. 
Factors of interest for these presentations include prehos-
pital causal factors, patient demographics, causal factors 
for AECOPD, ED management, ED assessment practices, 
ED referrals, patient experiences in the ED, holistic 
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Table 1 Data extraction domains and elaboration
Domain/subdomain Description
Article details
  Author Authors of article
  Year Article year of publication
  Country Country of origin
Study details
  Study aim Aim and purpose of the study
  Study design Study methodology, context and participant eligibility
  Participants Participant demographics and sample size
  Results Key results of the study
AECOPD ED presentation causal factors Characteristics of causal factors (or risk factors) reported as reason for AECOPD ED 
presentation (eg, environmental air pollution, respiratory infection, medication non-
compliance)
AECOPD ED management and assessment 
practices
Characteristics of AECOPD ED management and assessment practices
  AECOPD ED holistic management Characteristics of AECOPD ED holistic management (eg, multidisciplinary team)
AECOPD ED interventions Characteristics of AECOPD ED intervention practices including duration
AECOPD ED referral practices Characteristics of AECOPD ED referral practices
  Referral pathway Type of healthcare provider/service the patient with AECOPD was referred to by the 
ED (eg, pulmonary rehabilitation, palliative care, psychology, social work, pharmacy, 
physiotherapy, dietetics, nursing, smoking cessation)
  Non-referral Frequency of non-referral practices (eg, discharged home, mortality)
Patient outcome Discharge status, hospital admission, length of stay, mortality
  Representation to ED Rate of representation to ED with AECOPD within 24 hours, 7 days, 30 days, other
  Impact of referral pathway Impact of AECOPD ED referral patterns on patient outcomes
AECOPD, acute exacerbation of COPD; ED, emergency department.
management practice (multidisciplinary referrals in the 
ED), outcomes, admission/discharge status and readmis-
sion rates within 24 hours, 7 days, 30 days, other.
Stage 4: data extraction
Data will be obtained from included research articles 
using a data collection tool that has been developed by 
the authors (table 1). This tool will allow for the full 
description of known causal factors for AECOPD ED 
presentations and identified gaps in referral pathways. 
Specific data extracted (but not limited to) will include 
author, year of publication, country of origin, study popu-
lation and sample size (if applicable), methodology/
methods, characteristics of causal factors for AECOPD ED 
presentations, characteristics of AECOPD assessment and 
referral patterns, processes of AECOPD assessment and 
referral patterns, factors reported that relate to AECOPD 
assessment and referral patterns, interventions and dura-
tion of interventions (if applicable), impact of AECOPD 
assessment and referral patterns on patient outcomes (if 
applicable).
Stage 5: collating, summarising and reporting the results
Results will be shown in a schematic tabular format 
(figure 1), with a narrative summary depicting how 
presented results are linked with the scoping review 
objectives and overall research questions. The 
narrative summary will include highlighted areas for 
further research, with a particular emphasis on gaps in 
current interprofessional health management. Results 
will be categorised as key conceptual findings stemming 
from the data extraction process. These categories will 
align with the strategic intent of this review: (1) What 
are the known causal factors associated with COPD ED 
presentations and (2) Is there an identified connection 
with appropriate healthcare professional assessment 
within ED presentations and reported referral pathways?
Patient and public involvement
This scoping review is not primary research and will only 
be informed by previous published research. Therefore, 
there was no patient involvement in the research design, 
that is, no primary data collection, or analysis involving 
patients.
As this is a scoping review the development of the 
research question and outcome measures are only 
informed by patients’ priorities, experience and prefer-
ences as set out in existing published literature.
EthICS And dISSEMInAtIon
This scoping review will systematically explore current 
evidence to contribute and initiate holistic care for 
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Figure 1 PRISMA schematic tabular format of scoping 
review search outcome. Flow diagram depicting the 
different phases of article identification, screening of title 
and abstracts for initial eligibility, eligibility screening of full 
text articles to assess relevance for inclusion, and inclusion 
of studies for data extraction and synthesis. Adapted 
from Moher et al.21 PRISMA, Preferred Reporting Items for 
Systematic reviews and Meta-Analyses.
patients with COPD in the ED. Ethics approval was not 
required for this study. All data will be obtained from the 
three-tiered search strategy and will be reviewed by two 
researchers for consensus. A multidisciplinary team of 
authors in this scoping review will represent their special-
ities in knowledge translations and participate in dissem-
ination activities (publications, reports, conference 
presentations). Knowledge and interpretations from this 
review will inform development of assessment frame-
work with optimal referral patterns in the ED. Findings 
from this study will be presented before stakeholders and 
clinicians through iterations of a future modified Delphi 
Study to develop a COPD management framework for 
EDs. Findings of this scoping review will be presented at 
future Emergency Medicine Foundation conference.
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